Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Korian
  6. Summary
    KORI   FR0010386334

KORIAN

(KORI)
  Report
Real-time Euronext Paris  -  11:35:27 2023-02-03 am EST
9.010 EUR   -6.05%
01/11Korian Completes Purchase Of Spanish Mental Health Provider Grupo 5
MT
01/11Korian : Completion of Grupo 5 acquisition
PU
01/11Korian acquired Grupo 5 Acción y Gestión Social, S.A. from Corpfin Capital Asesores, S.A., SGEIC and others.
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
01/30/2023 01/31/2023 02/01/2023 02/02/2023 02/03/2023 Date
9.615(c) 9.595(c) 9.445(c) 9.59(c) 9.01(c) Last
340 007 276 392 736 553 657 642 1 419 622 Volume
+0.52% -0.21% -1.56% +1.54% -6.05% Change
More quotes
Estimated financial data (e)
Sales 2022 4 579 M 4 969 M 4 969 M
Net income 2022 82,8 M 89,9 M 89,9 M
Net Debt 2022 7 143 M 7 752 M 7 752 M
P/E ratio 2022 10,1x
Yield 2022 5,11%
Sales 2023 4 929 M 5 349 M 5 349 M
Net income 2023 119 M 130 M 130 M
Net Debt 2023 7 175 M 7 786 M 7 786 M
P/E ratio 2023 7,30x
Yield 2023 5,66%
Capitalization 937 M 1 017 M 1 017 M
EV / Sales 2022 1,76x
EV / Sales 2023 1,65x
Nbr of Employees 56 000
Free-Float 68,3%
More Financials
Company
Korian is the European No. 1 private operator of full-care facilities for dependent people. Net sales break down by geographic zone as follows: - France (50.7%): at the end of 2021, operated 571 facilities (35,523 beds) broken into assisted-living facilities (medical assisted living facilities for the elderly, retirement homes, long-term care facilities and rest homes) and medical facilities (follow-up care and... 
More about the company
Ratings of Korian
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about KORIAN
01/11Korian Completes Purchase Of Spanish Mental Health Provider Grupo 5
MT
01/11Korian : Completion of Grupo 5 acquisition
PU
01/11Korian acquired Grupo 5 Acción y Gestión Social, S.A. from Corpfin Capital Asesores, S...
CI
2022Korian Continues to Develop Its Home Care Solutions
CI
2022Korian acquired Casa di Cura Fondazione Gaetano e Piera Borghi S.r.l.
CI
2022Korian : Inside Information / Other news releases
PU
2022Korian To Open Three Specialized Clinics In France
MT
2022Korian Pursues the Development of Healthcare Activity in France, with Opening of 3 Inic..
CI
2022Korian : Document AMF CP. 2022E869863
PU
2022Korian : Q3 22 presentation_2710
PU
2022Korian : 27.10.22 Revenue Q3 2022_EN
PU
2022Korian : Q3 22 presentation
PU
2022French care homes firm Orpea to resume markets trading, present new plan
RE
2022Korian : Document AMF CP. 2022E866976
PU
2022Korian : Document AMF CP. 2022E866324
PU
More news
News in other languages on KORIAN
02/01Wall Street attend la Fed, l'Europe profite du ralentissement de l'inflation
02/01Point marchés-Wall Street attend la Fed, l'Europe profite du ralentissement de l'inflat..
02/01L'optimisme de retour en Europe avant l'inflation et la Fed
02/01Orpea annonce un accord avec la CDC et passe sous le contrôle de l'État
02/01L'optimisme de retour en Europe avant l'inflation et la Fed
More news
Analyst Recommendations on KORIAN
More recommendations
ETFs positioned on KORIANETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Lyxor CAC Mid 60 - Dist - EUR0.83%2.24%France
Lyxor MSCI EMU Small Cap (DR) - Dist - EUR0.28%2.49%Europe
UBS ETF ? MSCI EMU Small Cap A-dis - EUR0.19%4.65%Europe
Global X Longevity Thematic ETF - USD0.17%1.23%World
IShares MSCI Europe Small-Cap ETF - USD0.07%2.70%Europe
More ETFs positioned on KORIAN
Chart KORIAN
Duration : Period :
Korian Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KORIAN
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 9,01 €
Average target price 23,56 €
Spread / Average Target 162%
EPS Revisions
Managers and Directors
Sophie Boissard Chief Executive Officer & Director
Philippe Marie Bruno Garin Group Chief Financial Officer
Jean-Pierre Duprieu Chairman
Didier Armaingaud Director-Group Medical & Quality
Anne Lalou Independent Director